ADMA
ADMA BIOLOGICS, INC. · Healthcare · Market cap $2.1B
Insiders bought $251K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed May 28, 2026
Insider Buying
$468K
reported purchases (SEC code P)
Insider Selling
$2.2M
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Jul 29, 2026
Grossman Jerrold B
ADMA BIOLOGICS, INC. (ADMA) has 28 SEC Form 4 filings (52 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Jul 29, 2026.
Inside the rolling window, 4 insiders at ADMA BIOLOGICS, INC. reported 5 open-market purchases totaling $468K and 7 open-market sales totaling $2.2M. The most active filer is President and CEO Grossman Adam S with 6 filings. Insiders have net sold $346K over the trailing 6 months. The most recent open-market filing is a purchase of 6,400 shares by Director Grossman Jerrold B, dated May 27, 2026, worth $51K.
- Industry:Biotechnology
- CEO:Adam S. Grossman
- Employees:644
- HQ:Ramsey, NJ, US
- IPO:2013-10-17
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director | Purchase | 6,400 | $51K | May 28 | +16.4% | SEC ↗ | |
| Director | Purchase | 12,500 | $100K | May 14 | +8.6% | SEC ↗ | |
Grossman Jerrold BFirst filing | Director | Purchase | 12,500 | $100K | May 12 | +9.8% | SEC ↗ |
| President and CEO | Sale | 21,000 | $318K | Mar 17 | -42.8% | SEC ↗ | |
Kestenberg-Messina Kaitlin M.First filing | COO and SVP, Compliance | Sale | 10,096 | $158K | Mar 10 | -41.7% | SEC ↗ |
ELMS STEVEFirst filing | Director | Purchase | 7,000 | $110K | Mar 9 | -41.6% | SEC ↗ |
ELMS STEVEFirst filing | Director | Purchase | 7,000 | $108K | Mar 9 | -41.6% | SEC ↗ |
| President and CEO | Sale | 21,000 | $338K | Feb 17 | -42.1% | SEC ↗ | |
| President and CEO | Sale | 21,000 | $416K | Dec 16 | — | SEC ↗ | |
| President and CEO | Sale | 21,000 | $336K | Nov 21 | — | SEC ↗ | |
| President and CEO | Sale | 21,000 | $336K | Oct 24 | — | SEC ↗ | |
Grossman Adam SFirst filing | President and CEO | Sale | 21,000 | $339K | Sep 16 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does ADMA have?
ADMA BIOLOGICS, INC. (ADMA) has 28 SEC Form 4 filings (52 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Jul 29, 2026.
When was the most recent SEC Form 4 filing for ADMA?
The most recent Form 4 filing for ADMA on Tracefour is dated Jul 29, 2026.
Who is the most active insider at ADMA?
The most active SEC Form 4 filer at ADMA in the rolling window is President and CEO Grossman Adam S, with 6 filings.
What is the net insider flow at ADMA over the last 6 months?
Over the trailing 180 days, insiders at ADMA have net sold $346K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ADMA in the current window?
Inside the rolling window, insiders at ADMA bought $468K and sold $2.2M based on SEC Form 4 filings.
Can I get alerts for ADMA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at ADMA BIOLOGICS, INC. (ADMA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
ADMA BIOLOGICS, INC. is in the Healthcare sector.